Evidence map›Paper›PMID 36676114›Full record

ReviewLife (Basel, Switzerland)2023

Human Heart Morphogenesis: A New Vision Based on In Vivo Labeling and Cell Tracking.

Laura Villavicencio-Guzmán, Concepción Sánchez-Gómez, Ricardo Jaime-Cruz, Tania Cristina Ramírez-Fuentes, Carlos César Patiño-Morales, Marcela Salazar-García

Open access · goldAbstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Laura Villavicencio-GuzmánResearch Laboratory of Developmental Biology and Experimental Teratogenesis, Children's Hospital of México Federico Gomez, Mexico City 06720, Mexico.
Concepción Sánchez-GómezResearch Laboratory of Developmental Biology and Experimental Teratogenesis, Children's Hospital of México Federico Gomez, Mexico City 06720, Mexico.
Ricardo Jaime-CruzResearch Laboratory of Developmental Biology and Experimental Teratogenesis, Children's Hospital of México Federico Gomez, Mexico City 06720, Mexico.ORCID 0000-0002-0403-537X
Tania Cristina Ramírez-FuentesResearch Laboratory of Developmental Biology and Experimental Teratogenesis, Children's Hospital of México Federico Gomez, Mexico City 06720, Mexico.
Carlos César Patiño-MoralesResearch Laboratory of Developmental Biology and Experimental Teratogenesis, Children's Hospital of México Federico Gomez, Mexico City 06720, Mexico.ORCID 0000-0003-1995-0308
Marcela Salazar-GarcíaResearch Laboratory of Developmental Biology and Experimental Teratogenesis, Children's Hospital of México Federico Gomez, Mexico City 06720, Mexico.
Hospital Infantil de México Federico Gómez · MXUniversidad Autónoma Metropolitana · MX

Funding

Children's Hospital of Mexico Federico Gomez HIM-2019-057 and HIM/2017/029Posgraduate program in Experimental Biology of the Metropolitan Autonomous University CVU CONACYT:790019Posgraduate program, Medical Superior School of the National Polytechnic Institute CVU CONACYT: 853124.
6 · The paper itself

Abstract

Despite the extensive information available on the different genetic, epigenetic, and molecular features of cardiogenesis, the origin of congenital heart defects remains unknown. Most genetic and molecular studies have been conducted outside the context of the progressive anatomical and histological changes in the embryonic heart, which is one of the reasons for the limited knowledge of the origins of congenital heart diseases. We integrated the findings of descriptive studies on human embryos and experimental studies on chick, rat, and mouse embryos. This research is based on the new dynamic concept of heart development and the existence of two heart fields. The first field corresponds to the straight heart tube, into which splanchnic mesodermal cells from the second heart field are gradually recruited. The overall aim was to create a new vision for the analysis, diagnosis, and regionalized classification of congenital defects of the heart and great arteries. In addition to highlighting the importance of genetic factors in the development of congenital heart disease, this study provides new insights into the composition of the straight heart tube, the processes of twisting and folding, and the fate of the conus in the development of the right ventricle and its outflow tract. The new vision, based on in vivo labeling and cell tracking and enhanced by models such as gastruloids and organoids, has contributed to a better understanding of important errors in cardiac morphogenesis, which may lead to several congenital heart diseases.

Indexed as

cardiogenesiscell trackingembryoheart morphogenesis

Identifiers

PMID36676114
PMCPMC9861877
OpenAlexW4313647103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.